Concepedia

Author

Linda Godfrey

AstraZeneca (United Kingdom)

Also Known As

Linda Godfrey

6

Publications

225

Citations

6

H-Index

20

Concepts

All Affiliations

AstraZeneca (United Kingdom)
LG

About

Linda Godfrey is an author at AstraZeneca (United Kingdom) specializing in drug discovery, medicine, and biochemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

225

2

Biochemistry

6

6

225

3

Natural Sciences

4

4

138

4

Chemical Biology

2

2

40

5

Biomolecular Engineering

1

1

65

Linda Godfrey

×

6

Publications

225

Citations

6

H-Index

YearCitations

Structure-based design of protein tyrosine phosphatase-1B inhibitors

Emma Black, J. Breed, Alexander L. Breeze,

Bioorganic & Medicinal Chemistry Letters

2005

75

Discovery and Optimization of a Series of Carbazole Ureas as NPY5 Antagonists for the Treatment of Obesity

M. Block, Scott Boyer, Wayne Brailsford,

Journal of Medicinal Chemistry

2002

65

Property based optimisation of glucokinase activators – discovery of the phase IIb clinical candidate AZD1656

Michael J. Waring, David S. Clarke, Mark D. Fenwick,

MedChemComm

2012

33

Novel thienopyrrole glycogen phosphorylase inhibitors: Synthesis, in vitro SAR and crystallographic studies

Paul R. O. Whittamore, Matthew S. Addie, Stuart N. L. Bennett,

Bioorganic & Medicinal Chemistry Letters

2006

29

Optimisation of pharmacokinetic properties in a neutral series of 11β-HSD1 inhibitors

James S. Scott, Adrian L. Gill, Linda Godfrey,

Bioorganic & Medicinal Chemistry Letters

2012

12

Reduction of acyl glucuronidation in a series of acidic 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors: the discovery of AZD6925

James S. Scott, Peter Barton, Stuart N. L. Bennett,

MedChemComm

2012

11

Page 1